In addition, gastric cancer tissues and cell lines also expressed CD155, which combined with TIGIT to restrict the glucose uptake of CD8+ T cells and then weaken the function of CD8+ T cell effector molecules, causing these cells to exhibit functional failure and impairing their activation, proliferation, cytokine production, and metabolism. The gene discussed is CD8A; the disease is gastric cancer.